A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer
Condition: Anal Canal Squamous Cell Carcinoma Interventions: Drug: BI 754091; Drug: BI 836880 Sponsor: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials